comparemela.com

Latest Breaking News On - World health organization defeating meningitis - Page 1 : comparemela.com

New 5-in-1 meningitis vaccine shows promise

The results of a phase 3 clinical trial induced a strong immune response against five strains of the deadly bacteria.

India
Mali
Senegal
Ethiopia
Gambia
Research-council-unit
London-school-of-hygiene-tropical-medicine
Serum-institute-of-india
World-health-organization
World-health-organization-defeating-meningitis
New-england-journal

CanSino Biologics Inc.: CanSinoBIO Announces Approval for its MCV4 Product Menhycia in China

TIANJIN, China, Jan. 8, 2022 /PRNewswire/ CanSino Biologics Inc. ("CanSinoBIO") (SSE: 688185, HKEX: 06185) announced that the National Medical Products Administration of China ("NMPA") granted

China
Xuefeng
Hunan
Tianjin
Prnewswire-cansino-biologics-inc
National-medical-products-administration-of-china
World-health-organization-defeating-meningitis
Sino-biologics
National-medical-products-administration
Conjugate-vaccine
World-health-organization

CanSinoBIO Announces Approval for its MCV4 Product Menhycia™ in China

Press release content from PR Newswire. The AP news staff was not involved in its creation.

China
Xuefeng
Hunan
Tianjin
Prnewswire-cansino-biologics-inc
Cansino-biologics-inc
National-medical-products-administration-of-china
Groupc-meningococcal-conjugate-vaccine
World-health-organization-defeating-meningitis
Sino-biologics
National-medical-products-administration

CanSinoBIO Announces Approval for its MCV4 Product Menhycia™ in China

/PRNewswire/ CanSino Biologics Inc. ("CanSinoBIO") (SSE: 688185, HKEX: 06185) announced that the National Medical Products Administration of China ("NMPA").

China
Xuefeng
Hunan
Tianjin
Prnewswire-cansino-biologics-inc
National-medical-products-administration-of-china
World-health-organization-defeating-meningitis
Sino-biologics
National-medical-products-administration
Conjugate-vaccine
World-health-organization

CanSinoBIO Announces Approval for its MCV4 Product Menhycia™ in China

/PRNewswire/ CanSino Biologics Inc. ("CanSinoBIO") (SSE: 688185, HKEX: 06185) announced that the National Medical Products Administration of China ("NMPA").

China
Xuefeng
Hunan
Tianjin
Prnewswire-cansino-biologics-inc
National-medical-products-administration-of-china
World-health-organization-defeating-meningitis
Sino-biologics
National-medical-products-administration
Conjugate-vaccine
World-health-organization

vimarsana © 2020. All Rights Reserved.